Omalizumab is a humanized monoclonal antibody designed to target and bind to human immunoglobulin E (IgE). It is widely used in research to study allergic asthma and chronic spontaneous urticaria, facilitating both in vitro binding assays and in vivo models of allergic disease.
Konzentration:
75.4 mg/mL
Molekulargewicht:
149 kDa
Reinheit:
99.60% (May vary between batches)
CAS Nummer:
[242138-07-4]
Target-Kategorie:
Others,Interleukin
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten